Organ System

Abdominal

• UK SMI B 62: abdominal organ transport fluid testing (Jan 2020)

Cardiovascular

Endocarditis Therapy

• Guidelines for the management of infective endocarditis (ESC 2015) 
• Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the working party of BSAC (2012)
• Update on cardiovascular electronic implantable device infections and their management: A scientific statement from the American Heart Association (2010) [PDF]

• 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction

• Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)​​​​

Endocarditis Prophylaxis

• Prophylaxis against infective endocarditis: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedure (NICE 2008; Updated July 2016)

Neurological

Meningitis

• UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults (BIA - JoI 2016)
• Early management of suspected meningitis and meningococcal sepsis in immunocompetent adults (3rd edition, Jan 2016)
• Bacterial meningitis and meningococcal septicaemia: Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care (NICE 2010; Updated February 2015) 

Encephalitis

• Management of suspected viral encephalitis in adults (BIA - JoI 2012) 
• Management of suspected viral encephalitis in children (BIA - JoI 2012)

Respiratory

Coronavirus

• IDSA Coronavirus guidelines
• BMJ Best Practice coronavirus summary (and links to international guidelines)
• See also the BIA coronavirus resource page

 ​​​Pneumonia

• Pneumonia in adults: diagnosis and management (NICE 2014; Updated September 2019)
• 2015 - Annotated BTS guideline for the management of CAP in adults (2009) 
• Guidelines for the management of community-acquired pneumonia in children (BTS 2011 update)
• Pneumonia (community-acquired): antimicrobial prescribing
• Pneumonia (hospital-acquired): antimicrobial prescribing

Respiratory Tract Infections

Urinary

Urinary Tract Infections

• Urinary tract infection in under 16s: diagnosis and management (NICE 2007; Updated October 2018)  
• Archived pending update: ​​​​​​​Diagnosis, prevention, and treatment of catheter-associated urinary tract infections in adults: 2009 international clinical practice guidelines from IDSA

Cystitis

• Archived pending update: ​​​​​​​International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women (IDSA and ESCMID 2010 Update)

 

Organism

UK Public Health A-Z Guidance

• Public Health England: infectious diseases  
• Health Protection Scotland: A-Z of topics  
• Public Health Wales: Topics

Bacteria

Anthrax

• Guidelines: Cutaneous and Inhalation anthrax (National Archives 2012)

• Guidelines: Anthrax in heroin users (National Archives 2012)

Bordetella and Pertussis

• UK SMI ID 5: identification of Bordetella species (updated August 2020)

• Pertussis  – guidelines for public health management (updated May 2018)

Carbapenemase-producing Enterobacteriacea

• UK SMI B 60: detection of bacteria with carbapenem hydrolysing β lactamases (carbapenemases)

• Actions to contain carbapenemase-producing Enterobacterales (CPE) (October 2020)           

Cellulitis

• NICE Guideline: Cellulitis and erysipelas: antimicrobial prescribing (Sept 2019)

Clostridium difficile infection

• HPS Guidance on prevention and control of Clostridium difficile infection (CDI) in health and social care settings in Scotland (HPS Sept 2017)

• Update of the treatment guidance document for Clostridium difficile infection (ESCMID 2014)

• Clostridium difficile infection: guidance on management and treatment (PHE 2013) (Updated Sept 2019. New guidance due 2021)

Diptheria

• Public health control and management of diphtheria (in England and Wales) (2015)

Group A streptococcal infection

• *Group A Streptococcus - guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK (BIA; JoI 2012) 

Helicobacter pylori

• Test and treat for H. pylori in dyspepsia – quick reference guide for primary care

Listeria

• UK SMI ID 3: identification of Listeria species (March 2020)

Lyme disease

• NICE quality standard: Lyme Disease (July 2019)

• * The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: A position statement by the British Infection Association (BIA; JoI 2011) 

• NICE guideline on Lyme disease (April 2018)           

• EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis (2010) [PDF]

• IDSA 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease

Multi-resistant acinetobacter

• *Working party guidance on the control of multi-resistant acinetobacter outbreaks (AMM, BSAC, HPA, HIS, ICNA, DH 2006)

Multi-resistant Gram-negative bacteria

Staphylococcus aureus infection

• Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England (HPA 2008) 

• UK SMI ID 7: identification of Staphylococcus species, Micrococcus species and Rothia species

Mycobacteria

Leprosy

• Memorandum on leprosy (PHE 2012) 

• WHO guidelines for the diagnosis, treatment and prevention of leprosy (2017)

Tuberculosis

• Tuberculosis (NICE 2016)

• *BIS guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children (BIS; JoI 2009)

• WHO guidance for the treatment of isoniazid resistant TB

• WHO consolidated guidelines on drug-resistant TB treatment (2019)

Non-tuberculous mycobacteria

• BTS guidelines for the management of NTM pulmonary disease
• IDSA/ATS/ERS/ESCMID guidelines for treatment of NTM pulmonary disease

Fungi

Aspergillosis

• Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management (ESCMID, ERS 2016)

• Treatment of aspergillosis: IDSA Clinical Practice Guidelines (2016)

Blastomycosis

• Clinical Practice Guidelines for the management of blastomycosis (IDSA 2008 Update)

Candida

• Guideline for the diagnosis and management of Candida diseases (ESCMID 2012)

• Clinical Practice Guidelines for the management of candidiasis (IDSA 2016 Update)  

Coccidioidomycosis

• Coccidioidomycosis (IDSA 2016)             

Cryptococcus

• Clinical Practice Guidelines for the management of cryptococcal disease (IDSA 2010 Update)

Histoplasmosis

• Clinical Practice Guidelines for the management of patients with histoplasmosis  (IDSA 2007 Update)

Rare and emerging

• Guidelines on disgnosis and management of rare and emerging fungal diseases (ESCMID, EFISG, ECMM 2014)

Viruses

Covid-19

• UK SMI V 58: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) serology

• IDSA Covid treatment guidelines – regularly updated

Hepatitis

• EASL 2017 hepatitis B treatment guidelines

• Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults (NICE 2013)     

• Ledipasvir-sofosbuvir for treating chronic hepatitis C (NICE 2015)

• Daclatasvir for treating chronic hepatitis C (NICE 2015)

• Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C (NICE 2015)

• IDSA/AASLD HCV treatment guidelines (2020)

• EASL hepatitis B treatment guidelines (behind registration wall)

HIV

The following BHIVA guidelines are available at BHIVA.org:

• HIV-associated malignancies (2014)

• Management of HIV infection in pregnant women 2012 (2014 interim review)

• Management of hepatitis viruses in adults infected with HIV 2013 (Update Sept 2014)

• Treatment of HIV-1 positive adults with antiretroviral therapy 2015

• Routine investigation and monitoring of adult HIV-1-infected individuals (2011)

• Treatment of TB/HIV coinfection (2011)

• Treatment of opportunistic infection in HIV-seropositive individuals (2011)

• UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (PEPSE)2015

• Antiretroviral Treatment of HIV-2 Positive Individuals (2010)

• Determining HIV-1 tropism in routine clinical practice (2009)

• Use of vaccines in HIV-positive adults (2015)

• UK Guidelines for the management of sexual and reproductive health of people living with HIV infection (2008)

• UK National Guidelines for HIV Testing (2008)

Influenza

• Avian influenza: guidance and algorithms for managing human cases (PHE 2014)  

• PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza (2019) [PDF]

Measles

• PHE National Measles Guidelines (August 2019)

MERS CoV

• Infection control advice: Middle East respiratory syndrome coronavirus (MERS CoV) (PHE 2013) [PDF]

Norovirus

• *Guidelines for the management of norovirus outbreaks in acute and community health and social care settings (Norovirus Working Party 2012) [PDF]

Rabies

• PHE guidelines on managing rabies post-exposure (August 2020)   

Varicella

• *Chickenpox in adults – clinical management (BIS) (JoI 2008)

• Management of a viral rash in pregnancy PHE (March 2019) [PDF]

Viral Haemorrhagic Fevers

• Viral haemorrhagic fever: ACDP algorithm and guidance on management of patients (PHE, DH Updated 2015) 

• Ebola virus disease: clinical management and guidance (PHE, updated 2019)               

Parasites

Malaria

• Guidelines for malaria prevention in travellers from the UK
• *UK malaria treatment guidelines 2016 (JoI)

Leishmania

• IDSA/ASTMH guidelines for the diagnosis and treatment of leishmaniasis (2016)
• LesihMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travellers (2014)

Babesiosis

• IDSA guidelines on the diagnosis and management of babesiosis

Other Guidelines

Antimicrobial Prescribing

• Leg ulcer infection: antimicrobial prescribing

Antimicrobial Stewardship

• Antimicrobial stewardship: changing risk-related behaviours in the general population (NICE 2017)
• Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NICE 2015)

Biofilms

Cirrhosis

• Cirrhosis in over 16s: assesment and management (NICE 2016)

Chronic Fatigue Syndrome

• Chronic fatigue syndrome / myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children (NICE 2007) Update expected April 2021

Diabetic Foot

• Diabetic foot problems: prevention and management (NICE 2015) (Updated October 2019) 

Infection Control

• Infection Prevention and Control Commissioning Toolkit (IPS, RCN 2016) Currently under revision.
• Healthcare-associated infections: NICE quality standard (2016)
• Infection: Prevention and control of healthcare-associated infections in primary and community care (NICE 2012) (Updated 2017)   
• Surgical site infection: Prevention and treatment of surgical site infection (NICE 2019)

Immunocompromised Host

• Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients (NICE 2012)                    

Neonatology

• Antibiotics for early-onset neonatal infection: Antibiotics for the prevention and treatment of early-onset neonatal infection (NICE 2012)  
• Group B streptococcal disease, early onset (Green –top guideline no. 36)(RCOG 2017)

Pregnancy

• Guidance on viral rash in pregnancy: investigation, diagnosis and management of viral rash illness, or exposure to viral rash illness, in pregnancy (PHE 2019) [PDF]

Sepsis

• Sepsis: recognition, diagnosis and early management (NICE 2016) (Updated 2017)
• Surviving sepsis campaign guidelines for the management of sepsis in adults (2016)
• Surviving sepsis campaign guidelines for management of sepsis in children (2020)
• Surviving sepsis campaign website guidelines and resources
• Clinical guidelines for immunoglobulin use (2011) [PDF]

Travel Medicine

• *Fever in returned travellers presenting in the United Kingdom; Recommendations for investigation and initial management (BIA 2009) (JoI)
• *Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management (BIA 2010) (JoI)
• Clinical guidelines for immunoglobulin use (2011) [PDF]